Literature DB >> 32801805

Molecular Investigations of Linezolid Resistance in Enterococci OptrA Variants from a Hospital in Shanghai.

Pei Li1, Yang Yang1, Li Ding1, Xiaogang Xu1, Dongfang Lin1.   

Abstract

PURPOSE: The OptrA protein is a member of ATP-binding cassette (ABC) transporters, a transporter family which can confer resistance to oxazolidinone antibiotics by transferring plasmid. We aim to describe the distribution of optrA-harbored Enterococcus in Huashan hospital in 2017 and to address the effects of optrA mutations on the susceptibility of linezolid antibiotic drug.
METHODS: Linezolid-resistance-related genes were tested for Enterococcus by polymerase chain reaction (PCR) and then sequenced for amino acid substitution site analysis. Broth microdilution and agar dilution test were applied to determine the minimal inhibitory concentration (MIC) of linezolid for Enterococcus containing optrA. Pulsed field gel electrophoresis (PFGE) and multilocus sequence typing (MLST) were used to evaluate the genotypes of optrA-positive isolates. To verify the functions of two main optrA variants, optrA over-expressing strains were constructed.
RESULTS: Among 20 optrA-positive strains, only two were resistant to linezolid. No amino acid substitution existed in 23S rRNA V domain among Enterococcus faecalis. None had cfr, cfr(B) or cfr(C) genes. F101L and G4D/K/R or T150A were the main substitutions of ribosomal protein L4, L3, respectively. We found one Enterococcus faecium isolate co-contained optrA and poxtA and another E. faecalis isolate co-contained optrA and cfr(D), but they were not resistant to linezolid. Among 20 optrA-positive strains, ST-16 was the main type. Two main optrA variants KD (T112K, Y176D) and RDK (I104R, Y176D, E256K) slightly raised enterococci's MIC of linezolid.
CONCLUSION: OptrA exists in linezolid non-resistant enterococci with diverse amino acid substitutions. The variants play different roles in changing the MIC of linezolid.
© 2020 Li et al.

Entities:  

Keywords:  enterococci; linezolid; optrA; resistant

Year:  2020        PMID: 32801805      PMCID: PMC7414921          DOI: 10.2147/IDR.S251490

Source DB:  PubMed          Journal:  Infect Drug Resist        ISSN: 1178-6973            Impact factor:   4.003


Introduction

Enterococci are medically important opportunistic pathogen which are more common in hospital-acquired infections. Linezolid1 is the first clinically used oxazolidinone antibiotic for the treatment of multidrug-resistant (MDR) gram-positive infections, especially in vancomycin-resistant enterococci (VRE) and methicillin-resistant Staphylococcus aureus (MRSA).2 However, linezolid-resistant enterococci have been increasingly detected both in human and animals3 in recent years, which urgently demands to deepen our knowledge on its resistance mechanisms. The resistance of linezolid in enterococci can be caused by point substitutions in 23S rRNA V domain, the main reason for linezolid resistance.4 The 23S rRNA methyltransferase coding genes cfr,4 cfr(B), cfr(C)5 and cfr(D)6 and also amino acid substitutions in ribosomal proteins L3, L4,4 L22,7 and ABC-F family members including OptrA8 and PoxtA.9 How ABC-F proteins mediate antibiotic resistance has been in a long-standing dispute with both efflux and ribosome protection hypothesis competing mutually. Current studies seem inclined to the latter.10,11 The optrA, found in 2015, was reported for its ATP hydrolysis activity to be associated with linezolid resistance.12 Also, previous study reported that there were different amino acid substitutions in optrA.13 In this study, we investigated the molecular characterization of optrA-positive enterococci and explored the function of varied types of optrA on the linezolid susceptibility.

Materials and Methods

Bacterial Strains

We examined 573 strains collected in 2017 at Huashan hospital, a tertiary hospital from Shanghai in China (Table 1). All were enterococci identified by bioMerieux Vitek-2 Compact and were stored in 30% glycerol broth under −80°C. The culture medium used in this study were BHIA (Brain-Heart Infusion Agar), BHIB (BrainHeart Infusion Broth), MHA (Mullex-Hinton Agar) and MHB (Mullex-Hinton Broth) (Thermo Fisher Oxoid, England).
Table 1

The Distribution of Different Species of Enterococcus Isolates from Huashan Hospital in 2017

Bacterial StrainsNumber (n)Percentage
E. faecalis29651.66%
E. faecium26446.07%
E. avium91.57%
E. casseliflavus20.35%
E. gallinarum20.35%
Total573100.00%
The Distribution of Different Species of Enterococcus Isolates from Huashan Hospital in 2017

Screening of optrA and Other Linezolid Resistance Related Genes in Enterococci

The length of optrA is 1968 bp.8 We screened 573 enterococci mentioned above by using PCR. All DNA samples were amplified using primers optrA-F1 (5ʹ-CAGGTGGTCAGCGAACTAAGA-3ʹ) and optrA-R1 (5ʹ-AGCCAAGAGCAGTTCTGACC-3ʹ), of which the product size was 792 bp. The thermal conditions were 1 cycle of 94°C for 5 min followed by 30 cycles of 94°C for 30 s, 56°C for 30 s, and 72°C for 30 s and 72°C for 5 min to stop the extension step. Then, amplifications were carried out in the optrA-positive strains for getting the whole sequence of optrA and detecting the existence of cfr,14 cfr(B), cfr(C), poxtA and mutations in rplC, rplD,15 rplV, and 23S rRNA V domain16 which were associated with linezolid resistance. Primers of these amplifications were shown in .

Antimicrobial Susceptibility Testing

The MIC for all optrA-positive isolates were determined by broth microdilution and agar dilution tests following the recommendations given in the Clinical and Laboratory Standards Institute (CLSI) documents M100-ED28.17 Enterococcus faecalis ATCC29212 served as the quality control strain. These antimicrobial susceptibility tests involved 18 antibiotics (Shanghai Food and Drug Administration, Shanghai, China) which were listed in . All tests were performed by using broth microdilution except for fosfomycin which was practiced with agar dilution. In CLSI, the approved MIC testing of fosfomycin is agar dilution, and the agar media should be supplemented with 25 μg/mL of glucose-6-phosphate.

Molecular Typing of optrA-Positive Enterococci

The phylogenetic distance among isolates harboring optrA was analyzed by PFGE. The sequence typing (ST) of all optrA-positive enterococci were identified through MLST. The MLST analysis was on the basis of amplifying the seven housekeeping genes gdh, gyd, psts, gki, aroE, xpt, yqil in E. faecalis and the other seven genes atpa, ddl, gdh, purk, gyd, psts, adk in Enterococcus faecium. According to the sequences provided in PubMLST (), primers for MLST were designed. All STs were determined by using the Enterococcus MLST database ().

Determination on the Function of Various Types of optrA

From the study published in 2015,8 the optrA found in plasmid pE394 (GenBank accession no. KP399637.1) was defined as the wildtype. A plasmid called E. faecalis JH2-2_pAM401ΩoptrA was constructed to confirm that the optrA could result in the resistance of linezolid in enterococci. Therefore, in our research, in order to investigate the effects of the amino acid substitutions of optrA on linezolid resistance, we followed the steps in the aforementioned article for the construction of the plasmid OG1RF_pABG5.0ΩoptrA (wildtype and mutations). pABG5.018 served as the shuttle vector which could exist both in Escherichia coli and E. faecalis. In-Fusion HD Cloning Kits (Takara) were used in the experiment. After the successful construction, the plasmid was transferred into OG1RF,19 a linezolid susceptible E. faecalis (MIC=2μg/mL), and then the optrA-positive clones were selected for further antimicrobial susceptibility test.

Results

The Distribution of optrA and Its Molecular Types

In all 573 strains isolated from Huashan hospital in 2017, we detected 20 optrA-positive isolates, numbered as 8, 37, 91, 154, 155, 185, 216, 223, 280, 297, 366, 397, 402, 404, 413, 421, 422, 446, 550, and 551, which accounted for 3.48% of the total strains. In Table 2, we could see that there were 14 optrA variants with 1 to 6 alterations at different positions. I104R, T112K, Y176D, and E256K were the most common amino acid substitutions; 18 of 20 strains were separated into 14 various STs, and the remaining two strains could not be identified in known STs.
Table 2

Twenty optrA-Positive Strains Were Numbered and Their MLST Types Were Listed as Shown Below. We Found the Existence of Various optrA Mutations Among Those 20 Which Presented Diverse MICs of Linezolid. According to CLSI, The Criteria of Judging Susceptibility Included Susceptible (MIC≤2μg/mL), Intermediate (MIC=4μg/mL), Resistant (MIC≥8μg/mL)

IsolatesSpeciesoptrA VariantoptrASTMIC (μg/mL)
8efaKDT112K, Y176D3308
37efaRDKI104R, Y176D, E256K6894
91efaoptrAE394No mutations4762
154efmDG40D3621
155efaoptrAE394No mutations1344
185efaRDKCI104R, Y176D, E256K, S399C3764
216efaKDT112K, Y176D4602
223efaDMY176D, I622M161
280efaKVT112K, F642V161
297efaoptrAE394No mutations44
366efaDPY176D, T481P694
397efaoptrAE394No mutations4762
402efmDDY176D, G393D/2
404efaKHRDIPT157K, Y158H, K160R, Y176D, V249I, T481P692
413efmNDMD247N, G393D, I622M3232
421efmDNDMY176D, D247N, G393D, I622M557≤0.5
422efmKT112K782
446efaRKI104R, E256K/4
550efaRDKI104R, Y176D, E256K162
551efaNI24N5858

Notes: K: Lys, D: Asp, R: Arg, C: Cys; M: Met, T: Thr; V: Val, E: Glu, H: His; I: Ile, P: Pro; N: Asn.

Twenty optrA-Positive Strains Were Numbered and Their MLST Types Were Listed as Shown Below. We Found the Existence of Various optrA Mutations Among Those 20 Which Presented Diverse MICs of Linezolid. According to CLSI, The Criteria of Judging Susceptibility Included Susceptible (MIC≤2μg/mL), Intermediate (MIC=4μg/mL), Resistant (MIC≥8μg/mL) Notes: K: Lys, D: Asp, R: Arg, C: Cys; M: Met, T: Thr; V: Val, E: Glu, H: His; I: Ile, P: Pro; N: Asn. The detection and amino acid substitutions of other linezolid-resistant-related genes were presented in . All genes amplified above were compared with the sequences from E. faecalis and E. faecium attainable in NCBI. ( and ). None amino acid substitution of 23S rRNA V domain was detected in E. faecalis. None of these 20 strains contained cfr, cfr(B), cfr(C) genes while 397 harbored cfr(D) gene. Nineteen strains had F101L mutations of L4, while no mutation of L22 was found, and G4K/D/R were the main mutation sites of L3. Only one strain possessed both optrA and poxtA. For further study on whether there was the dissemination of optrA in Huashan hospital, we performed PFGE and MLST. Similarity among 20 strain patterns was figured out by computerized band analysis with Bionumerics software version 3.3. This part of results could be seen in . No obvious homology was found in these 20 strains harboring optrA. The results of the antimicrobial susceptibility testing were shown in . All strains were resistant to tetracycline, kanamycin, erythromycin, and ciprofloxacin while they were susceptible to vancomycin and teicoplanin. The distribution of resistance in the remaining 8 antibiotics were followed by ampicillin (5/20, 25%), penicillin (5/20, 25%), linezolid (2/20, 10%), rifampicin (5/20, 20%), chloramphenicol (15/20, 75%), and fosfomycin (3/20, 15%). Only one strain was found with tigecycline MIC as 4 μg/mL. The imipenem MIC of 4 strains were equal to or over 8 μg/mL. More detailed tests on linezolid were further put into practice. Only two strains were found as linezolid resistant, obtained by broth microdilution separately.

Function of Two Types of optrA Variants in Linezolid Resistance

Isolates 8 (optrA-KD) and 37 (optrA-RDK) were found containing the most common alterations of optrA among these 20 strains. Based on this result, they were chosen for the transformation. The successful transformants (designated OG1RF_pABG5.0ΩoptrA-KD and OG1RF_pABG5.0ΩoptrA-RDK) exhibited 2 to 4 folds increase in the MIC of linezolid compared with the recipient strain OG1RF (Table 3).
Table 3

MICs for Clinical E. faecalis with optrA Variants, Their Transformants and Recipient Strains

Bacterial IsolatesLinezolid
MIC/μg/mL
Clinical E. faecalis
 HS0914 (wildtype)8
 8 (KD)8
 37 (RDK)4
Recipient strain
 OG1RF2
 Transformants OG1RF_pABG5.02
 Transformants OG1RF_pABG5.0ΩoptrA (wildtype)8
 Transformants OG1RF_pABG5.0ΩoptrA (KD)4
 Transformants OG1RF_pABG5.0ΩoptrA (RDK)4

Notes: HS0914: optrA with no mutation; KD: T112K, Y176D type; RDK: I104R, Y176D, E256K type.

MICs for Clinical E. faecalis with optrA Variants, Their Transformants and Recipient Strains Notes: HS0914: optrA with no mutation; KD: T112K, Y176D type; RDK: I104R, Y176D, E256K type.

Discussion

In 2017, E. faecalis and E. faecium were two main types of bacterial pathogens isolated from Huashan hospital. The detection rate of optrA in 573 strains was not high. ST-16 was the type that commonly existed among 14 STs (3/20) as mentioned in Table 2 which coincided with the common type of enterococci harboring optrA in other districts.20,21 These comparisons indicated that optrA was carried by low-homology enterococci isolates. The results of the antimicrobial susceptibility tests have revealed that multidrug-resistant enterococci were not the minority. Resistance levels of linezolid in enterococci containing optrA were unevenly distributed. Through the method of broth microdilution, only two strains were detected with low linezolid resistant level (MIC=8 μg/mL). This conceded that optrA was not only present in linezolid-resistant enterococci. At the same time, 20 strains harboring optrA had different numbers of amino acid substitutions. In the preliminary experiments, the successful construction of optrA over-expressing strains had shown that KD (T112K, Y176D) (BankIt2317497 KD MT122998) and RDK (I104R, Y176D, E256K) (BankIt2317550 RDK MT122999) optrA variants were able to raise linezolid MIC but could not reach the MIC as shown in the wildtype optrA in pE349. Potential mechanisms of mutations that affected the level of resistance of the bacteria to linezolid deserve further study. However, not all types of variants were used to construct the plasmid for over-expressing the optrA. Interestingly, 91 and 397 with no mutation of optrA were susceptible to linezolid (MIC=2 μg/mL). Whether optrA gene expressed and translated or there were some other mechanisms antagonizing the ribosome protection mechanism which led to the loss of drug resistance phenotype will be another avenue of research. Screening of other linezolid-resistant genes showed that the cfr, cfr(B), and cfr(C) detection rates were zero, which were consistent to the results of MIC. Only one E. faecalis was detected to carry cfr(D).In this year, a study from europe characterized the novel cfr(D) gene identified in an E. faecium clinical isolate.6 According to the results mentioned above, it might probably that the cfr(D) gene tended to transfer between two kinds of Enterococcus. Whether it played a role of conferring linezolid resistance in Enterococcus still needs to be explored. F101L mutation of L3 protein was common among 19 strains. Whether it participated in the process of linezolid resistance remains to be confirmed. For lack of the mature techniques of gene knockout in Enterococcus, it is not easy to verify the concrete functions of these substitutions. The newly discovered PoxtA, which also belongs to ABC-F proteins, shares 32% homology identity with OptrA. Of the 20 strains, only 402 had OptrA (Y176D, G393D) and PoxtA (no alterations). Surprisingly these two displayed no synergistic effects because its MIC showed that it was a susceptible one. Whether they existed in one plasmid, like pE035 obtained from swine carrying both optrA and poxtA,22 or neither was expressed or had other negative interactions is vague at the moment. Moreover, since 421 was extremely susceptible to linezolid (MIC<0.5 μg/mL), whether its regulatory region was interfered still needs to be checked. In conclusion, although the detection rate of optrA in Enterococcus spp. isolates was not high, and there was no obvious evidence of its dissemination in hospital, its role in linezolid resistance still needs to be noted. OptrA mutations affected the linezolid resistance at varying degrees. Detailed mechanisms such as how optrA variants interact with linezolid are of more need to be clarified.
  21 in total

1.  Analysis of a poxtA- and optrA-co-carrying conjugative multiresistance plasmid from Enterococcus faecalis.

Authors:  Wenbo Hao; Xinxin Shan; Dexi Li; Stefan Schwarz; Su-Mei Zhang; Xin-Sheng Li; Xiang-Dang Du
Journal:  J Antimicrob Chemother       Date:  2019-07-01       Impact factor: 5.790

2.  Emergence of a plasmid-borne multidrug resistance gene cfr(C) in foodborne pathogen Campylobacter.

Authors:  Yizhi Tang; Lei Dai; Orhan Sahin; Zuowei Wu; Mingyuan Liu; Qijing Zhang
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

3.  A novel gene, optrA, that confers transferable resistance to oxazolidinones and phenicols and its presence in Enterococcus faecalis and Enterococcus faecium of human and animal origin.

Authors:  Yang Wang; Yuan Lv; Jiachang Cai; Stefan Schwarz; Lanqing Cui; Zhidong Hu; Rong Zhang; Jun Li; Qin Zhao; Tao He; Dacheng Wang; Zheng Wang; Yingbo Shen; Yun Li; Andrea T Feßler; Congming Wu; Hao Yu; Xuming Deng; Xi Xia; Jianzhong Shen
Journal:  J Antimicrob Chemother       Date:  2015-05-14       Impact factor: 5.790

4.  Molecular and functional analysis of the novel cfr(D) linezolid resistance gene identified in Enterococcus faecium.

Authors:  François Guerin; Mohamed Sassi; Loren Dejoies; Asma Zouari; Sacha Schutz; Sophie Potrel; Michel Auzou; Anaïs Collet; Didier Lecointe; Gabriel Auger; Vincent Cattoir
Journal:  J Antimicrob Chemother       Date:  2020-07-01       Impact factor: 5.790

5.  Dose dependence of emergence of resistance to linezolid in Enterococcus faecalis in vivo.

Authors:  Nadège Bourgeois-Nicolaos; Laurent Massias; Brigitte Couson; Marie-José Butel; Antoine Andremont; Florence Doucet-Populaire
Journal:  J Infect Dis       Date:  2007-04-03       Impact factor: 5.226

Review 6.  Linezolid, the first oxazolidinone antibacterial agent.

Authors:  Karen L Leach; Steven J Brickner; Mark C Noe; Paul F Miller
Journal:  Ann N Y Acad Sci       Date:  2011-03       Impact factor: 5.691

7.  Investigation of mechanism and molecular epidemiology of linezolid-resistant Enterococcus faecalis in China.

Authors:  Lipeng Wang; Yunyan He; Yun Xia; Huijuan Wang; Shumei Liang
Journal:  Infect Genet Evol       Date:  2014-05-09       Impact factor: 3.342

Review 8.  Mechanisms of antibiotic resistance in enterococci.

Authors:  William R Miller; Jose M Munita; Cesar A Arias
Journal:  Expert Rev Anti Infect Ther       Date:  2014-10       Impact factor: 5.091

9.  Contribution of autolysin and Sortase a during Enterococcus faecalis DNA-dependent biofilm development.

Authors:  Pascale S Guiton; Chia S Hung; Kimberly A Kline; Robyn Roth; Andrew L Kau; Ericka Hayes; John Heuser; Karen W Dodson; Michael G Caparon; Scott J Hultgren
Journal:  Infect Immun       Date:  2009-06-15       Impact factor: 3.441

10.  Intracellular Accumulation of Linezolid and Florfenicol in OptrA-Producing Enterococcus faecalis and Staphylococcus aureus.

Authors:  Yingyu Wang; Xiaowei Li; Yang Wang; Stefan Schwarz; Jianzhong Shen; Xi Xia
Journal:  Molecules       Date:  2018-12-04       Impact factor: 4.411

View more
  5 in total

1.  Antimicrobial Susceptibility of Enterococcus Isolates from Cattle and Pigs in Portugal: Linezolid Resistance Genes optrA and poxtA.

Authors:  Joana Gião; Célia Leão; Teresa Albuquerque; Lurdes Clemente; Ana Amaro
Journal:  Antibiotics (Basel)       Date:  2022-05-03

2.  Emergence of optrA-Mediated Linezolid Resistance in Enterococcus faecium: A Molecular Investigation in a Tertiary Hospital of Southwest China from 2014-2018.

Authors:  Miao Yi; Jiaqi Zou; Jinxin Zhao; Yu Tang; Yaling Yuan; Bingxue Yang; Jinzhu Huang; Peiwen Xia; Yun Xia
Journal:  Infect Drug Resist       Date:  2022-01-04       Impact factor: 4.003

3.  Comparison of Anti-Microbic and Anti-Biofilm Activity Among Tedizolid and Radezolid Against Linezolid-Resistant Enterococcus faecalis Isolates.

Authors:  Lingbo Wang; Ying Zhang; Shixing Liu; Na Huang; Weiliang Zeng; Wenya Xu; Tieli Zhou; Mo Shen
Journal:  Infect Drug Resist       Date:  2021-11-05       Impact factor: 4.003

Review 4.  Enterococcus Virulence and Resistant Traits Associated with Its Permanence in the Hospital Environment.

Authors:  Catarina Geraldes; Luís Tavares; Solange Gil; Manuela Oliveira
Journal:  Antibiotics (Basel)       Date:  2022-06-26

5.  Mobile Oxazolidinone Resistance Genes in Gram-Positive and Gram-Negative Bacteria.

Authors:  Stefan Schwarz; Wanjiang Zhang; Xiang-Dang Du; Henrike Krüger; Andrea T Feßler; Shizhen Ma; Yao Zhu; Congming Wu; Jianzhong Shen; Yang Wang
Journal:  Clin Microbiol Rev       Date:  2021-06-02       Impact factor: 50.129

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.